Human Medications, Human Drugs, Animal Medications, Animal Drugs, Pharmacy law, Pharmaceutical law, Compounding law, Sterile and Non Sterile Compounding 797 Compliance, Veterinary law, Veterinary Compounding Law; Health Care; Awareness of all Types of Compounding Issues; Pharmacy Benefit Managers (PBMs), Outsourcing Facilities Food and Drug Administration and Compliance Issues
Thursday, July 12, 2012
President Obama Signs First Federal Synthetic Drug Law
President Obama has signed The Synthetic Drug Abuse Prevention Act of 2012 - law, which will add 26 chemicals to the Schedule I list of the Controlled Substances Act; extend the executive authority of the DEA over synthetic drugs to three years; and criminalize the manufacture, distribution, sale, and use of certain synthetic drugs-including a minimum 20 year sentence for those who are directly responsible for the death or injury of another person by manufacturing, distribution or sales of synthetic drugs.
Previously, under the DEA Temporary Ban, the DEA had the power to ban new and emerging drugs if they and the U.S. Department of Health and Human Services could demonstrate within 18 months that the drug was harmful and lacked medicinal or industrial value. The new law will allow and additional 18 months so that the DEA can conduct the complex requisite research and scientific analysis to support a final scheduling determination.
To read remainder of article, click here.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment